Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia

Journal of Hypertension

Volumn 23, Issue 2, 2005, Pages 367-374

  Solini, Anna ^a   Santini, Eleonora ^a   Ferrannini, Ele ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Angiotensin II; Atherosclerosis; Endothelin 1; Familial hypercholesterolemia; Fibroblast; Transforming growth factor 1

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CALCIUM ION; GELATINASE A; INTERSTITIAL COLLAGENASE; IRBESARTAN; LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIBROBLAST; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 14044278826     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200502000-00019     Document Type: Article

References (43)

1. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000; 101:1130-1137.
2. Brand T, Schneider MD. The TGF beta superfamily in myocardium: ligands, receptors, transduction, and function. J Mol Cell Cardiol 1995; 27:5-18.
3. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 2002; 14:681-685.
4. Lee AA, Dillmann WH, McCulloch AD, Villareal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995; 27: 2347-2357.
5. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998; 40:352-363.
6. Piacentini L, Gray M, Honbo NY, Chentoufi J, Bergman M, Karliner JS. Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C. J Mol Cell Cardiol 2000; 32:565-576.
7. Blouquit S, Sari A, Lombet A, D'Herbomez M, Naline E, Matran R, Chinet T. Effects of endothelin-1 on epithelial ion transport in human airways. Am J Respir Cell Mol Biol 2003; 29:245-251.
8. King-VanVlack CE, Mewburn JD, Chapler CK, MacDonald PH. Hemodynamic and proinflammatory actions of endothelin-1 in guinea pig small intestine submucosal microcirculation. Am J Physiol Gastrointest Liver Physiol 2003; 284:G940-G948.
9. Nickenig G, Sachinidis A, Michaelsen F, Bohm M, Seewald S, Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation 1997; 95:473-478.
10. Nickenig G, Baumer AT, Temur Y, Kebben D, Jockenhovel F, Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 1999; 100:2131-2134.
11. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99:2503-2509.
12. Chen YL, Wu HW, Jiang MJ. Transforming growth factor-beta1 gene and protein expression associated with atherogenesis of cholesterol-fed rabbits. Histol Histopathol 2000; 15:421-428.
13. 1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition with pravastatin. J Am Coll Cardiol 2002; 39:1752-1757.
14. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991; 303:893-896.
15. Williams B. Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol 2001; 87(8A):10C-17C.
16. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35:881-900.
17. Strehlow K, Wassmann S, Bohm M, Nickenig G. Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med 2000; 32:386-389.
18. Wierzbicki AS, Lambert-Hammill M, Lumb PJ, Crook MA. Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia. Hypertension 2000; 36:808-812.
19. Ceolotto G, Valente R, Baritono E, Reato S, Iori E, Monari A, et al. Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts. Hypertension 2001; 37:1486-1491.
20. Paragh G, Kovacs E, Seres I, Keresztes T, Balogh Z, Szabo J, et al. Altered signal pathway in granulocytes from patients with hypercholesterolemia. J Lipid Res 1999; 40:1728-1733.
21. Allen S, Khan S, Al-Mohanna F, Batten P, Yacoub M. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 1998; 101:1064-1075.
22. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999; 33:613-621.
23. 1. J Clin Invest 2002; 109:715-716.
24. Fan J, Unoki H, Iwasa S, Watanabe T. Role of endothelin-1 in atherosclerosis. Ann N Y Acad Sci 2000; 902:84-94.
25. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 1994; 269:1110-1119.
26. Bakris GL, Re RN. Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 1993; 264:F937-F942.
27. Katsuda S, Okada Y, Minamoto T, Oda Y, Matsui Y, Nakanishi I. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb 1992; 12:494-502.
28. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 88:2503-2509.
29. Lemaitre V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001; 107:1227-1234.
30. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26:809-820.
31. Rizzoni D, Rodella R, Porteri E, Mezzani R, Sleiman I, Paiardi S, et al. Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats. Clin Exp Hypertens 2003; 25:427-441.
32. Rizzoni D, Rossi GP, Porteri E, Sticchi E, Rodella L, Rezzani R, et al. Bradykinin and matrix metalloproteinases are involved in prevention of structural alterations of rat small arteries during inhibition of ACE and NEP. J Hypertens 2004; 22:759-766.
33. Seeger H, Lippert C, Wallwiener D, Mueck AO. Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function. J Renin Angiotensin Aldosterone Syst 2001; 2:141-143.
34. Orbe J, Rodriguez JA, Arias R, Belzunce M, Nespereira B, Perez-Ilzarbe M, et al. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implication for plaque stabilization. Atherosclerosis 2003; 167:45-53.
35. Chen H, Li D, Mehta JL. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2002; 39:332-339.
36. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001; 280:C53-C60.
37. Strawn WB, Ferrario CM. Mechanisms linking angiotensin II and atherogenesis. Curr Opin Lipidol 2002; 13:505-512.
38. Cawston T. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today 1998; 4:130-137.
39. Ivan E, Khatri JJ, Johnson C, Magid R, Godin D, Nandi S, et al. Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content: the murine model of macrophage-rich carotid artery lesions. Circulation 2002; 105:2686-2691.
40. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 2003; 369:485-496.
41. Papakonstantinou E, Roth M, Kokkas B, Papadopoulos C, Karakiulakis G. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells. J Cardiovasc Pharmacol 2001; 38:715-728.
42. Zhang X, O'Malley Y, Robbins ME. Angiotensin II-induced modulation of rat mesangial cell phenotype. Radiat Res 1999; 151:725-735.
43. 1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Biochem Biophys Res Commun 2002; 299:555-561.